Neuropsychological impact of west nile virus infection: An extensive neuropsychiatric assessment of 49 cases in Canada

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Samaan, Zainab ^a,b   Vaz, Stephanie Mcdermid ^a,c   Bawor, Monica ^a,b   Potter, Tammy Hlywka ^a   Eskandarian, Sasha ^a   Loeb, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CANADA; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; ENCEPHALITIS; FATIGUE; FEMALE; FLACCID PARALYSIS; HEALTH CARE PERSONNEL; HUMAN; LABORATORY TEST; LEARNING; MALE; MENINGITIS; NEUROPSYCHOLOGICAL TEST; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; WEST NILE FEVER; WEST NILE VIRUS; AGED; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; ONTARIO;

ADULT; AGED; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; WEST NILE FEVER;

EID: 84978032876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158364     Document Type: Article

References (77)

1. Smithburn K, Hughes T, Burke A, Paul J: A neurotropic virus isolated from the blood of a native of Uganda. American Journal of Tropical Medicine 1940, 20:471-472
2. Hayes C: West Nile Fever. In: The arboviruses: epidemiology and ecology. Volume V, edn. Edited by Monath T. Boca Raton, Florida: CRC Press; 1989: 59-88
3. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al: The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001, 344(24):1807-1814. PMID: 11407341
4. West Nile Virus Activity-United States, 2003. MMWR Morb Mortal Wkly Rep
5. PHAC: Public Health Agency of Canada. Human West Nile virus cases and asymptomatic infections in Canada. In.; 2007
6. Sampson BA, Armbrustmacher V: West Nile encephalitis: the neuropathology of four fatalities. Ann N Y Acad Sci 2001, 951:172-178. PMID: 11797775
7. Shieh WJ, Guarner J, Layton M, Fine A, Miller J, Nash D, et al:: The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis 2000, 6(4):370-372 PMID: 10905969
8. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al:: Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. The lancet 2001, 358(9278):261-264
9. Petersen LR, Marfin AA: West Nile virus: a primer for the clinician. In: Ann Intern Med. Volume 137, edn. United States; 2002: 173-179
10. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI: West Nile encephalitis epidemic in southeastern Romania. In: Lancet. Volume 352, edn. England; 1998: 767-771
11. Mostashari F, Poshni I, Edwin B, Layton M, Graham D, Bradley C, et al:: Serosurveys for West Nile virus infection-New York and Connecticut counties 2000.MMWR Morbidity and Mortality Weekly Report 2001, 50(3):37-39. PMID: 11215880
12. Petersen LR, Marfin AA, Gubler DJ: West Nile virus. In: JAMA. Volume 290, edn. United States; 2003: 524-528
13. Johnson RT, Irani DN: West Nile virus encephalitis in the United States. Curr Neurol Neurosci Rep 2002, 2(6):496-500. PMID: 12359102
14. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, et al:: Neurologic manifestations and outcome of West Nile virus infection. In: JAMA. Volume 290, edn. United States; 2003: 511-515
15. Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, Fine A, et al:: Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004, 10(8):1405-1411. PMID: 15496241
16. Berner YN, Lang R, Chowers MY: Outcome of West Nile fever in older adults. In: J Am Geriatr Soc. Volume 50, edn. United States; 2002: 1844-1846
17. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, et al:: Clinical characteristics and functional outcomes of West Nile Fever. In: Ann Intern Med. Volume 141, edn. United States; 2004: 360-365
18. Gottfried K, Quinn R, Jones T: Clinical description and follow-up investigation of human West Nile virus cases. South Med J 2005, 98(6):603-606. PMID: 16004166
19. Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, Bergloff P, et al:: Long-term clinical and neuropsychological outcomes of West Nile virus infection. In: Clin Infect Dis. Volume 43, edn. United States; 2006: 723-730
20. Murray KO, Resnick M, Miller V: Depression after infection with West Nile virus. Emerg Infect Dis 2007, 13(3):479-481. PMID: 17552106
21. Ou AC, Ratard RC: One-year sequelae in patients with West Nile Virus encephalitis and meningitis in Louisiana. J La State Med Soc 2005, 157(1):42-46. PMID: 15887668
22. Haaland KY, Sadek J, Pergam S, Echevarria LA, Davis LE, Goade D, et al:: Mental status after West Nile virus infection. Emerg Infect Dis 2006, 12(8):1260-1262. PMID: 16965710
23. Patnaik JL, Harmon H, Vogt RL: Follow-up of 2003 human West Nile virus infections, Denver, Colorado Emerg Infect Dis 2006, 12(7):1129-1131. PMID: 16836833
24. Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Pape J, Biggerstaff BJ, et al:: West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis 2006, 12(3):514-516. PMID: 16704798
25. Loeb M, Hanna S, Nicolle L, Eyles J, Elliott S, Rathbone M, et al:: Prognosis after West Nile virus infection In: Ann Intern Med. Volume 149, edn. United States; 2008: 232-241
26. Sadek JR, Pergam SA, Harrington JA, Echevarria LA, Davis LE, Goade D, et al: Persistent neuropsychological impairment associated with West Nile virus infection. In: J Clin Exp Neuropsychol. Volume 32, edn. England; 2010: 81-87
27. Hart J Jr., Tillman G, Kraut MA, Chiang HS, Strain JF, Li Y, et al:: West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. In: BMC Infect Dis. Volume 14, edn. England; 2014: 248
28. Berg PJ, Smallfield S, Svien L: An investigation of depression and fatigue post West Nile virus infection S D Med 2010, 63(4):127-129, 131-123. PMID: 20397375
29. Nolan MS, Hause AM, Murray KO: Findings of long-term depression up to 8 years post infection from West Nile virus. J Clin Psychol 2012, 68(7):801-808. doi: 10.1002/jclp.21871 PMID: 23929558
30. Anastasiadou A, Kakoulidis I, Butel D, Kehagia E, Papa A: Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis 2013, 17(7):e494-497. doi: 10.1016/j.ijid.2012.12.006 PMID: 23317528
31. Bravo G, Dubois MF, Hebert R, De Wals P, Messier L: A prospective evaluation of the Charlson Comorbidity Index for use in long-term care patients. In: J Am Geriatr Soc. Volume 50, edn. United States; 2002: 740-745
32. Brown TA, Chorpita BF, Korotitsch W, Barlow DH: Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. In: Behav Res Ther. Volume 35, edn. England; 1997: 79-89
33. Crawford JR, Henry JD: The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003, 42(Pt 2):111-131. PMID: 12828802
34. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46(10):1121-1123 PMID: 2803071
35. Grace J, Mendelsohn A, Friedman JH: A comparison of fatigue measures in Parkinson's disease. Parkinsonism Relat Disord 2007, 13(7):443-445. PMID: 17055331
36. Lynch WJ: Determination of effort level, exaggeration, and malingering in neurocognitive assessment J Head Trauma Rehabil 2004, 19(3):277-283. PMID: 15247849
37. Lezak MD: Neuropsychological assessment: Oxford university press; 2004
38. Strauss E, Sherman EM, Spreen O: A compendium of neuropsychological tests: Administration, norms, and commentary: Oxford University Press; 2006
39. Tombaugh TN: The Test of Memory Malingering (TOMM): Normative data from cognitively intact and cognitively impaired individuals. Psychological Assessment 1997, 9(3):260
40. Etherton JL, Bianchini KJ, Greve KW, Ciota MA: Test of Memory Malingering Performance is unaffected by laboratory-induced pain: implications for clinical use. In: Arch Clin Neuropsychol. Volume 20, edn. United States; 2005: 375-384
41. Rees LM, Tombaugh TN, Boulay L: Depression and the Test of Memory Malingering. In: Arch Clin Neuropsychol Volume 16, edn. United States; 2001: 501-506
42. Slick DJ, Tan JE, Strauss EH, Hultsch DF: Detecting malingering: a survey of experts' practices. In: Arch Clin Neuropsychol. Volume 19, edn. United States: 2003 National Academy of Neuropsychology; 2004: 465-473
43. Brandt J, Benedict RH: Hopkins verbal learning test-revised: professional manual: Psychological Assessment Resources; 2001
44. Benedict R, Schretlen D, Brandt J, Groninger L: Revision of the Hopkins verbal learning test: reliability and normative data. Clin Neuropsychol 1998, 12:43-55
45. Carey C, Woods S, Rippeth J, Gonzalez R, Moore D, Marcotte T, et al:: Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. The Clinical Neuropsychologist 2004, 18(2):234-248. PMID: 15587671
46. De Jager CA, Hogervorst E, Combrinck M, Budge MM: Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med 2003, 33(6):1039-1050. PMID: 12946088
47. Shapiro AM, Benedict RH, Schretlen D, Brandt J: Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol 1999, 13(3):348-358. PMID: 10726605
48. Benedict RH: Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis. In: J Int Neuropsychol Soc. Volume 11, edn. England; 2005: 727-736
49. Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, et al: A summary of the FDA-NIMHMATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. In: Schizophr Bull. Volume 31, edn. United States; 2005: 5-19.
50. Morey CE, Cilo M, Berry J, Cusick C: The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study. In: Brain Inj. Volume 17, edn. England; 2003: 809-815
51. Culbertson W, Zilmer E: Tower of London-DX 2nd Edition (TOL-DX 2nd Edition) Technical Manual. In North Tonawanda, NY: Multi-Health Systems; 2004
52. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, French-Constant C, Rubinsztein DC, et al:: Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998, 121 (Pt 7):1329-1341. PMID: 9679784
53. Morris RG, Downes JJ, Sahakian BJ, Evenden JL, Heald A, Robbins TW: Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 1988, 51(6):757-766. PMID: 3404183
54. Hughes C, Plumet MH, Leboyer M: Towards a cognitive phenotype for autism: increased prevalence of executive dysfunction and superior spatial span amongst siblings of children with autism. J Child Psychol Psychiatry 1999, 40(5):705-718. PMID: 10433405
55. Benton A, Hamsher K: Multilingual Aphasia Examination Manual In. Iowa City, USA: University of Iowa; 1976
56. Ruff RM, Light RH, Parker SB, Levin HS: Benton Controlled Oral Word Association Test: reliability and updated norms. In: Arch Clin Neuropsychol. Volume 11, edn. United States; 1996: 329-338
57. DesRosiers G, Kavanagh D: Cognitive assessment in closed head injury: Stability, validity and parallel forms for two neuropsychological measures of recovery. International Journal of Clinical Neuropsychology 1987
58. Golden C: Stroop Color and Word Test: A manual for clinical and experiemental uses. In. Chicago, IL: Stoelting Co; 1978
59. Golden C, Freshwater S: Stroop Color and Word Test: Revised examiner's manual. In. Wood Dale, IL: Steolting Co; 2002
60. MacLeod CM: Half a century of research on the Stroop effect: an integrative review. Psychol Bull 1991, 109(2):163-203. PMID: 2034749
61. West R, Bell MA: Stroop color-word interference and electroencephalogram activation: evidence for age-related decline of the anterior attention system. Neuropsychology 1997, 11(3):421-427. PMID: 9223146
62. Mead LA, Mayer AR, Bobholz JA, Woodley SJ, Cunningham JM, Hammeke TA, et al:: Neural basis of the Stroop interference task: response competition or selective attention? J Int Neuropsychol Soc 2002, 8(6):735-742. PMID: 12240737
63. Wechsler D: WAIS-III Administration and Scoring Manual. In. San Antonio, TX: The Psychological Corporation; 1997
64. Ryan JJ, Paolo AM: Exploratory factor analysis of the WAIS-III in a mixed patient sample. Archives of Clinical Neuropsychology 2001, 16(2):151-156. PMID: 14590183
65. Groth-Marnat G, Gallagher R, Hale J, Kaplan E: Wescsler Intelligence Scales. In: Neuropsychological assessmeent in clinical practice. edn. Edited by Groth-Marnat G. New York: Wiley; 2000: 129-194
66. Smith A: Symbol Digit Modalities Test (SDMT) manual (revised). In. Los Angeles, CA: Western Psychological Services; 1982
67. Ponsford J, Kinsella G: Attentional deficits following closed-head injury. J Clin Exp Neuropsychol 1992, 14(5):822-838. PMID: 1474148
68. Einarsson U, Gottberg K, Fredrikson S, Bergendal G, von Koch L, Holmqvist LW: Multiple sclerosis in Stockholm County. A pilot study exploring the feasibility of assessment of impairment, disability and handicap by home visits. Clin Rehabil 2003, 17(3):294-303. PMID: 12735537
69. Benton A, Hamsher KdS, Varney N, Spreen O: Contributions to neuropsychological assessment Oxford Univ. Press, New York 1983
70. Ng VW, Eslinger PJ, Williams SC, Brammer MJ, Bullmore ET, Andrew CM, et al:: Hemispheric preference in visuospatial processing: a complementary approach with fMRI and lesion studies. In: Hum Brain Mapp. Volume 10, edn. United States; 2000: 80-86
71. Instructions for the Grooved Pegboard Test. In. Lafayette, Indiana: Lafayette Instrument Company; 1989
72. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370(9596):1453-1457. PMID: 18064739
73. Couderc T, Guivel-Benhassine F, Calaora V, Gosselin AS, Blondel B: An ex vivo murine model to study poliovirus-induced apoptosis in nerve cells. J Gen Virol 2002, 83(Pt 8):1925-1930
74. Xiao SY, Guzman H, Zhang H, Travassos da Rosa AP, Tesh RB: West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis 2001, 7(4):714-721. PMID: 11585537
75. Sugamata M, Miyazawa M, Mori S, Spangrude GJ, Ewalt LC, Lodmell DL: Paralysis of street rabies virus-infected mice is dependent on T lymphocytes. J Virol 1992, 66(2):1252-1260. PMID: 1731103
76. Iwasaki Y, Zhao JX, Yamamoto T, Konno H: Immunohistochemical demonstration of viral antigens in Japanese encephalitis. Acta Neuropathol 1986, 70(1):79-81. PMID: 3014801
77. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF, Deacon RM, et al:: Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biological psychiatry 2009, 65(4):304-312. doi: 10.1016/j.biopsych.2008.07.024 PMID: 18801476